John Christopher Kingswood
Overview
Explore the profile of John Christopher Kingswood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mekahli D, Muller R, Marlais M, Wlodkowski T, Haeberle S, de Argumedo M, et al.
Nat Rev Nephrol
. 2024 Mar;
20(6):402-420.
PMID: 38443710
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the presence of proliferative lesions throughout the body. Management of TSC is challenging because patients have a multifaceted systemic...
2.
Budde K, Zonnenberg B, Frost M, Cheung W, Urva S, Brechenmacher T, et al.
Br J Clin Pharmacol
. 2015 Nov;
81(5):958-70.
PMID: 26580489
Aims: The purpose was to determine the exposure-response relationship of everolimus in patients with angiomyolipoma from the EXIST-2 trial and to analyze the correlation between exposure and plasma concentrations of...
3.
Bissler J, Kingswood J, Radzikowska E, Zonnenberg B, Frost M, Belousova E, et al.
Nephrol Dial Transplant
. 2015 Jul;
31(1):111-9.
PMID: 26156073
Background: Mammalian target of rapamycin (mTOR) inhibitors are recommended as first-line treatment of renal angiomyolipoma associated with tuberous sclerosis complex (TSC) or sporadic lymphangioleiomyomatosis (sporadic LAM), but follow-up is limited....